Whole-body x-ray dark-field radiography of a human cadaver.

Dark-field imaging Human body Radiography Whole-body imaging X-rays

Journal

European radiology experimental
ISSN: 2509-9280
Titre abrégé: Eur Radiol Exp
Pays: England
ID NLM: 101721752

Informations de publication

Date de publication:
26 01 2021
Historique:
received: 22 07 2020
accepted: 03 12 2020
entrez: 26 1 2021
pubmed: 27 1 2021
medline: 3 2 2022
Statut: epublish

Résumé

Grating-based x-ray dark-field and phase-contrast imaging allow extracting information about refraction and small-angle scatter, beyond conventional attenuation. A step towards clinical translation has recently been achieved, allowing further investigation on humans. After the ethics committee approval, we scanned the full body of a human cadaver in anterior-posterior orientation. Six measurements were stitched together to form the whole-body image. All radiographs were taken at a three-grating large-object x-ray dark-field scanner, each lasting about 40 s. Signal intensities of different anatomical regions were assessed. The magnitude of visibility reduction caused by beam hardening instead of small-angle scatter was analysed using different phantom materials. Maximal effective dose was 0.3 mSv for the abdomen. Combined attenuation and dark-field radiography are technically possible throughout a whole human body. High signal levels were found in several bony structures, foreign materials, and the lung. Signal levels were 0.25 ± 0.13 (mean ± standard deviation) for the lungs, 0.08 ± 0.06 for the bones, 0.023 ± 0.019 for soft tissue, and 0.30 ± 0.02 for an antibiotic bead chain. We found that phantom materials, which do not produce small-angle scatter, can generate a strong visibility reduction signal. We acquired a whole-body x-ray dark-field radiograph of a human body in few minutes with an effective dose in a clinical acceptable range. Our findings suggest that the observed visibility reduction in the bone and metal is dominated by beam hardening and that the true dark-field signal in the lung is therefore much higher than that of the bone.

Sections du résumé

BACKGROUND
Grating-based x-ray dark-field and phase-contrast imaging allow extracting information about refraction and small-angle scatter, beyond conventional attenuation. A step towards clinical translation has recently been achieved, allowing further investigation on humans.
METHODS
After the ethics committee approval, we scanned the full body of a human cadaver in anterior-posterior orientation. Six measurements were stitched together to form the whole-body image. All radiographs were taken at a three-grating large-object x-ray dark-field scanner, each lasting about 40 s. Signal intensities of different anatomical regions were assessed. The magnitude of visibility reduction caused by beam hardening instead of small-angle scatter was analysed using different phantom materials. Maximal effective dose was 0.3 mSv for the abdomen.
RESULTS
Combined attenuation and dark-field radiography are technically possible throughout a whole human body. High signal levels were found in several bony structures, foreign materials, and the lung. Signal levels were 0.25 ± 0.13 (mean ± standard deviation) for the lungs, 0.08 ± 0.06 for the bones, 0.023 ± 0.019 for soft tissue, and 0.30 ± 0.02 for an antibiotic bead chain. We found that phantom materials, which do not produce small-angle scatter, can generate a strong visibility reduction signal.
CONCLUSION
We acquired a whole-body x-ray dark-field radiograph of a human body in few minutes with an effective dose in a clinical acceptable range. Our findings suggest that the observed visibility reduction in the bone and metal is dominated by beam hardening and that the true dark-field signal in the lung is therefore much higher than that of the bone.

Identifiants

pubmed: 33495889
doi: 10.1186/s41747-020-00201-1
pii: 10.1186/s41747-020-00201-1
pmc: PMC7835263
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Références

J Comput Assist Tomogr. 2015 Mar-Apr;39(2):286-9
pubmed: 25786094
Sci Rep. 2018 Oct 24;8(1):15700
pubmed: 30356116
Invest Radiol. 2014 Oct;49(10):653-8
pubmed: 24853070
Sci Rep. 2015 Dec 01;5:17492
pubmed: 26619958
Phys Med Biol. 2013 Apr 21;58(8):2713-32
pubmed: 23552903
PLoS One. 2019 Jun 3;14(6):e0217858
pubmed: 31158251
PLoS One. 2018 Sep 27;13(9):e0204565
pubmed: 30261038
Med Phys. 2020 Apr;47(4):1813-1826
pubmed: 31977070
Phys Med Biol. 2017 Aug 01;62(16):6729-6745
pubmed: 28762340
PLoS One. 2013;8(3):e59526
pubmed: 23555692
Invest Radiol. 2020 Aug;55(8):494-498
pubmed: 32251019
Sci Rep. 2014 Nov 28;4:7243
pubmed: 25430623
Rev Sci Instrum. 2007 Apr;78(4):043710
pubmed: 17477673
Sci Rep. 2019 Mar 12;9(1):4199
pubmed: 30862865
Opt Express. 2005 Aug 8;13(16):6296-304
pubmed: 19498642
Sci Rep. 2018 Feb 1;8(1):2096
pubmed: 29391514
Sci Rep. 2018 Feb 8;8(1):2602
pubmed: 29422512
Sci Rep. 2017 Nov 3;7(1):14477
pubmed: 29101369
Phys Med Biol. 2013 Feb 21;58(4):N37-46
pubmed: 23369954
Nat Mater. 2008 Feb;7(2):134-7
pubmed: 18204454
Sci Rep. 2017 Jul 6;7(1):4807
pubmed: 28684858
Sci Rep. 2016 Jun 30;6:29108
pubmed: 27357449
EBioMedicine. 2015 Aug 13;2(10):1500-6
pubmed: 26629545
Eur Radiol Exp. 2019 Jul 11;3(1):25
pubmed: 31292790
Sci Rep. 2016 Nov 14;6:36991
pubmed: 27841341
Opt Express. 2015 Sep 7;23(18):23462-71
pubmed: 26368446
Eur Radiol. 2018 Sep;28(9):3742-3750
pubmed: 29374322
Appl Opt. 2011 Aug 1;50(22):4310-9
pubmed: 21833104
Phys Med. 2014 May;30(3):352-7
pubmed: 24316287
Sci Rep. 2017 Mar 24;7(1):402
pubmed: 28341830
Med Phys. 2015 Apr;42(4):1959-65
pubmed: 25832086
Rev Sci Instrum. 2017 Jan;88(1):015104
pubmed: 28147659
Sci Rep. 2013 Nov 13;3:3209
pubmed: 24220606
IEEE Trans Med Imaging. 2019 Feb;38(2):649-656
pubmed: 30188818
Invest Radiol. 2016 Oct;51(10):597-601
pubmed: 27603110
Radiology. 2015 May;275(2):553-61
pubmed: 25531388
Eur Radiol Exp. 2018;2(1):1
pubmed: 29708215
Eur Radiol. 2020 Nov 19;:
pubmed: 33211140
Sci Rep. 2016 Apr 13;6:24269
pubmed: 27072871
Opt Express. 2010 Aug 2;18(16):16890-901
pubmed: 20721081
Radiology. 2013 Nov;269(2):427-33
pubmed: 23696682
Invest Radiol. 2015 Jul;50(7):430-5
pubmed: 25761095
Eur Radiol. 2020 Mar;30(3):1419-1425
pubmed: 31440834
Sci Rep. 2017 Jul 27;7(1):6711
pubmed: 28751744
Med Phys. 2016 Jun;43(6):2774-2779
pubmed: 27277024
Med Phys. 2018 Jun;45(6):2565-2571
pubmed: 29582440
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):17880-5
pubmed: 23074250

Auteurs

Jana Andrejewski (J)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany. jana.andrejewski@tum.de.

Fabio De Marco (F)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.

Konstantin Willer (K)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.

Wolfgang Noichl (W)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.

Alex Gustschin (A)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.

Thomas Koehler (T)

Philips Research, 22335, Hamburg, Germany.

Pascal Meyer (P)

Institute of Microstructure Technology, Karlsruhe Institute of Technology, 76344, Eggenstein-Leopoldshafen, Germany.

Fabian Kriner (F)

Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München, 80336, Munich, Germany.

Florian Fischer (F)

Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München, 80336, Munich, Germany.

Christian Braun (C)

Institut für Rechtsmedizin, Ludwig-Maximilians-Universität München, 80336, Munich, Germany.

Alexander A Fingerle (AA)

Department of Diagnostic and Interventional Radiology, Technical University of Munich, 81675, Munich, Germany.

Julia Herzen (J)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.

Franz Pfeiffer (F)

Chair of Biomedical Physics, Department of Physics and Munich School of BioEngineering, Technical University of Munich, 85748, Garching, Germany.
Department of Diagnostic and Interventional Radiology, Technical University of Munich, 81675, Munich, Germany.

Daniela Pfeiffer (D)

Department of Diagnostic and Interventional Radiology, Technical University of Munich, 81675, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH